These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38801945)
1. Stereotactic radiotherapy vs whole brain radiation therapy in EGFR mutated NSCLC: Results & reflections from the prematurely closed phase III HYBRID trial. Zeng M; Verma V; Chen X; Li S; Sun Y; Liu G; Tian X; Zhang D; Li J; Liu Y; Liao X; Liu Y; Wang L; Wang X; Shi H; Li B; Xue B; Luo X Radiother Oncol; 2024 Aug; 197():110334. PubMed ID: 38801945 [TBL] [Abstract][Full Text] [Related]
2. Clinical research on stereotactic radiosurgery combined with epithermal growth factor tyrosine kinase inhibitors in the treatment of brain metastasis of non-small cell lung cancer. Jia F; Cheng X; Zeng H; Miao J; Hou M J BUON; 2019; 24(2):578-584. PubMed ID: 31128009 [TBL] [Abstract][Full Text] [Related]
4. Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy. Press RH; Zhang C; Cassidy RJ; Ferris MJ; Zhong J; Steuer CE; Pillai RN; Owonikoko TK; Kahn S; Ramalingam SS; Patel PR; Curran WJ; Shu HG; Sica GL; Higgins KA Cancer; 2018 Sep; 124(17):3586-3595. PubMed ID: 30120912 [TBL] [Abstract][Full Text] [Related]
5. Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases. Miyawaki E; Kenmotsu H; Mori K; Harada H; Mitsuya K; Mamesaya N; Kawamura T; Kobayashi H; Nakashima K; Omori S; Wakuda K; Ono A; Naito T; Murakami H; Endo M; Nakasu Y; Gon Y; Takahashi T Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):604-613. PubMed ID: 30851347 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study. Zhai X; Li W; Li J; Jia W; Jing W; Tian Y; Xu S; Li Y; Zhu H; Yu J Radiat Oncol; 2021 Dec; 16(1):233. PubMed ID: 34865626 [TBL] [Abstract][Full Text] [Related]
7. Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial. Yang JJ; Zhou C; Huang Y; Feng J; Lu S; Song Y; Huang C; Wu G; Zhang L; Cheng Y; Hu C; Chen G; Zhang L; Liu X; Yan HH; Tan FL; Zhong W; Wu YL Lancet Respir Med; 2017 Sep; 5(9):707-716. PubMed ID: 28734822 [TBL] [Abstract][Full Text] [Related]
8. [Timing of Whole Brain Radiotherapy on Survival of Patients with EGFR-mutated Non-small Cell Lung Cancer and Brain Metastases]. Liu G; Zhang X; Tian C; Xia G; Liu P; Zhang Q; Li X; Zhang H; Qin N; Wang J; Zhang S Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):501-7. PubMed ID: 27561798 [TBL] [Abstract][Full Text] [Related]
9. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320. Sperduto PW; Wang M; Robins HI; Schell MC; Werner-Wasik M; Komaki R; Souhami L; Buyyounouski MK; Khuntia D; Demas W; Shah SA; Nedzi LA; Perry G; Suh JH; Mehta MP Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1312-8. PubMed ID: 23391814 [TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of EGFR mutation status in association with the efficacy of TKI in combination with WBRT/SRS/surgery plus chemotherapy in brain metastasis from non-small cell lung cancer. Cai L; Zhu JF; Zhang XW; Lin SX; Su XD; Lin P; Chen K; Zhang LJ J Neurooncol; 2014 Nov; 120(2):423-30. PubMed ID: 25098700 [TBL] [Abstract][Full Text] [Related]
11. Whole-brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non-small cell lung cancer: A single-institution study. Qing D; Zhao B; Zhou YC; Zhu HL; Ma DY Cancer Med; 2020 Jan; 9(1):238-246. PubMed ID: 31749325 [TBL] [Abstract][Full Text] [Related]
12. Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis. Fuentes R; Osorio D; Expósito Hernandez J; Simancas-Racines D; Martinez-Zapata MJ; Bonfill Cosp X Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012086. PubMed ID: 30125049 [TBL] [Abstract][Full Text] [Related]
13. Whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases: a multicenter, open-label, randomized, controlled phase III trial. Yang Z; Zhang Y; Li R; Yisikandaer A; Ren B; Sun J; Li J; Chen L; Zhao R; Zhang J; Xia X; Liao Z; Carbone DP Neuro Oncol; 2021 Jun; 23(6):967-978. PubMed ID: 33331923 [TBL] [Abstract][Full Text] [Related]
14. Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases. Wang J; Liu Z; Pang Q; Zhang T; Chen X; Er P; Wang Y; Wang P; Wang J BMC Cancer; 2020 Sep; 20(1):837. PubMed ID: 32883221 [TBL] [Abstract][Full Text] [Related]
15. Excellent Outcomes with Radiosurgery for Multiple Brain Metastases in ALK and EGFR Driven Non-Small Cell Lung Cancer. Robin TP; Camidge DR; Stuhr K; Nath SK; Breeze RE; Pacheco JM; Liu AK; Gaspar LE; Purcell WT; Doebele RC; Kavanagh BD; Rusthoven CG J Thorac Oncol; 2018 May; 13(5):715-720. PubMed ID: 29269007 [TBL] [Abstract][Full Text] [Related]
16. Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer. Doherty MK; Korpanty GJ; Tomasini P; Alizadeh M; Jao K; Labbé C; Mascaux CM; Martin P; Kamel-Reid S; Tsao MS; Pintilie M; Liu G; Bradbury PA; Feld R; Leighl NB; Chung C; Shepherd FA Radiother Oncol; 2017 May; 123(2):195-202. PubMed ID: 28363487 [TBL] [Abstract][Full Text] [Related]
17. Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases. Magnuson WJ; Yeung JT; Guillod PD; Gettinger SN; Yu JB; Chiang VL Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):673-9. PubMed ID: 27034176 [TBL] [Abstract][Full Text] [Related]
18. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial. Aoyama H; Tago M; Shirato H; JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254 [TBL] [Abstract][Full Text] [Related]
19. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC). Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291 [TBL] [Abstract][Full Text] [Related]
20. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer. Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]